Cathie Wood’s Ark Invest increased bets on biotechnology and AI, purchasing significant shares of Meta Platforms, Beam Therapeutics, CRISPR Therapeutics, and Intellia Therapeutics. The firm also added positions in Archer Aviation and Robinhood Markets. Conversely, Ark reduced exposure to Alphabet, Advanced Micro Devices, Palantir Technologies, and several healthcare stocks including Twist Bioscience and Tempus AI.
Cathie Wood's Ark weekly recap: buys Meta, gene-editing stocks while cutting Alphabet
Login to unlock417characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.